LNA Sante

LNA Sante SA Formerly known as Le Noble Age. LNA Sante SA, formerly known as Le Noble Age SA is a France-based company that owns and operates retirement homes and complexes for elderly residents. The Company's residences provide care and assistance for elderly people with a variety of needs, from those with a high level of independence, to those who are completely dependent. LNA Sante SA is also engaged in real estate operations. The Company has residences in France and Belgium. LNA Sante SA operates through its several subsidiaries, including Le Parc de Diane Sarl, Institut Medicalise de Mar Vivo, Gerhome, Residence le Point du Jour and the home healthcare service provider ARAIR Assistance, as well as ARAIR Group's support and training services, among others.
  • TickerLNA
  • ISINFR0004170017
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

Alain William ...
  • Christophe-Raphaël Ganet
  • François Maury
  • Georges Dieng
  • Hela Zarrouk
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 05/08/2019

...

Alain William ...
  • Christophe-Raphaël Ganet
  • François Maury
  • Georges Dieng
  • Hela Zarrouk
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 08/05/2019

...

Christophe-Raphaël Ganet

LNA Santé : Q1 2019 revenues in line with management’s guidance, neutral momentum

>Q1: +7.1% and 4% organically - Q1 operating revenues stood at € 113m, up 7.1% and +4% at constant consolidation scope.Revenues from the long stay segment (nursing homes France and Belgium, representing 57% of operating revenues) came in at € 64.2m, up 3.3% on a reported basis, driven by solid organic growth (+2.8%). Revenues from follow-up care, rehabilitation, home hospitalisation and psychiatric services were up 12.5% to € 48.4m. This growth was evenly sp...

Christophe-Raphaël Ganet

LNA Santé : CA T1 2019 en phase avec la trajectoire guidée du management – Momentum neutre

>T1 : +7.1% et 4% organique - Les revenus Exploitation du T1 ont atteint 113 M€, soit une hausse de 7.1% et +4% à périmètre comparable.L’activité du secteur Long Séjour (Ehpad France et Belgique, soit 57% des revenus d’Exploitation) s’élève à 64.2 M€, en hausse de 3.3% en publié, portée par une solide croissance organique (+2.8%). L’activité SSR, Psychiatrie et Hospitalisation à Domicile génère une croissance de 12.5% (48.4 M€). Cette progression se compose ...

Bruno de La Rochebrochard

LNA SANTÉ: Q1 revenue: a mixed picture by business but online in total | BUY | EUR68

LNA SANTÉ - BUY | EUR68 Q1 revenue: a mixed picture by business but online in total Mixed picture in organic revenue growth 2019 outlook confirmed

Bruno de La Rochebrochard

LNA Santé: Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Brief Comment - LNA Santé: (BUY, Fair Value EUR68 (+24%)) Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Alain William ...
  • Christophe-Raphaël Ganet
  • François Maury
  • Georges Dieng
  • Hela Zarrouk
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 05/08/2019

...

Alain William ...
  • Christophe-Raphaël Ganet
  • François Maury
  • Georges Dieng
  • Hela Zarrouk
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 08/05/2019

...

Christophe-Raphaël Ganet

LNA Santé : Q1 2019 revenues in line with management’s guidance, neutral momentum

>Q1: +7.1% and 4% organically - Q1 operating revenues stood at € 113m, up 7.1% and +4% at constant consolidation scope.Revenues from the long stay segment (nursing homes France and Belgium, representing 57% of operating revenues) came in at € 64.2m, up 3.3% on a reported basis, driven by solid organic growth (+2.8%). Revenues from follow-up care, rehabilitation, home hospitalisation and psychiatric services were up 12.5% to € 48.4m. This growth was evenly sp...

Christophe-Raphaël Ganet

LNA Santé : CA T1 2019 en phase avec la trajectoire guidée du management – Momentum neutre

>T1 : +7.1% et 4% organique - Les revenus Exploitation du T1 ont atteint 113 M€, soit une hausse de 7.1% et +4% à périmètre comparable.L’activité du secteur Long Séjour (Ehpad France et Belgique, soit 57% des revenus d’Exploitation) s’élève à 64.2 M€, en hausse de 3.3% en publié, portée par une solide croissance organique (+2.8%). L’activité SSR, Psychiatrie et Hospitalisation à Domicile génère une croissance de 12.5% (48.4 M€). Cette progression se compose ...

Bruno de La Rochebrochard

LNA SANTÉ: Q1 revenue: a mixed picture by business but online in total | BUY | EUR68

LNA SANTÉ - BUY | EUR68 Q1 revenue: a mixed picture by business but online in total Mixed picture in organic revenue growth 2019 outlook confirmed

1 director sold

A director at Lna Sante Sa sold 500 shares at 55.178EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board memb...

Christophe-Raphaël Ganet ...
  • Jean Sassus
  • Martial Descoutures
  • Pierre Corby
  • Steven Gould

ODDO BHF Small & MIDCAP MORNING NEWS - 04/04/2019

...

Christophe-Raphaël Ganet ...
  • Jean Sassus
  • Martial Descoutures
  • Pierre Corby
  • Steven Gould

ODDO BHF Small & MIDCAP MORNING NEWS - 04/04/2019

...

Alain William ...
  • Benoit Valleaux
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Michael Foundoukidis
  • Nicolas Thorez
  • Roland Pfaender

ODDO BHF Small & MIDCAP MORNING NEWS - 02/06/2019 Date Performance since listing Date Performance since listing

...

Alain William ...
  • Benoit Valleaux
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Michael Foundoukidis
  • Nicolas Thorez
  • Roland Pfaender

ODDO BHF Small & MIDCAP MORNING NEWS - 06/02/2019 Date Performance depuis l’entrée Date Performance depuis l’entrée

...

Baptiste Lebacq ...
  • Christophe-Raphaël Ganet
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 11/20/2018

...

For LNA SANTE SA, the environment deterioration entails a downgrade to Neutral

LNA SANTE SA (FR), a company active in the Health Care Providers industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 2 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date March 15, 2019, the closing price was EUR 46.45 and its expected value was estimated at EUR 46.37.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Proxy Report - 20/06/2018

Parmi les résolutions proposées par la société, six portent sur la rémunération des dirigeants. Même si les montants indiqués semblentraisonnables, l'absence de communication du bonus annuel total ne nous permet pas de les soutenir (résolutions 10 à 15). En raison de montants demandés trop élevés et de la possibilité d'utilisation en période d'o?re publique, la majorité des autorisations d'augmentation de capital demandées sera refusée (résolutions 18 à 21 et 23 et 24).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch